Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06364280 · ClinicalTrials.gov registry record · NA

Pediatric Prehospital Airway Resuscitation Trial

A NA study of Critical Illness and Wounds and Injuries, sponsored by Ohio State University.

Recruiting
Registry status
NA
Development phase
3,000
Enrollment target
10
Study locations

NCT06364280: Recruiting NA study of Critical Illness and Wounds and Injuries, sponsored by Ohio State University.

NCT06364280 is a NA study of Critical Illness and Wounds and Injuries that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 3,000 participants, roughly in line with the 3,105-participant average among 91 other Critical Illness trials with a reported enrollment target. The trial reports 10 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06364280, a NA study of Critical Illness and Wounds and Injuries, is actively recruiting participants, sponsored by Ohio State University.

RECRUITING
Registry status
NA
Development phase
3,000 participants
Enrollment target
10
Study locations

Study Summary

This study is a Phase 3, multi-center, Bayesian Adaptive Sequential Platform Trial testing the effectiveness of different prehospital airway management strategies in the care of critically ill children. Emergency Medical Services (EMS) agencies affiliated with the Pediatric Emergency Care Applied Research Network (PECARN) will participate in the trial. The study interventions are strategies of prehospital airway management: \[BVM-only\], \[BVM followed by SGA\] and \[BVM followed by ETI\]. The primary outcome is 30-day ICU-free survival. The trial will be organized and executed in two successive stages. In Stage I of the trial, EMS personnel will alternate between two strategies: \[BVM-only\] or \[BVM followed by SGA\]. The \[winner of Stage I\] will advance to Stage II based upon results of Bayesian interim analyses. In Stage II of the trial, EMS personnel will alternate between \[BVM followed by ETI\] vs. \[Winner of Stage I\].

Conditions Studied

Critical Illness Wounds and Injuries Child, Only Heart Arrest, Out-Of-Hospital Respiratory Insufficiency in Children

Interventions

  • DEVICE BVM
  • DEVICE SGA
  • DEVICE ETI

Study Locations (10)

California

  • Harbor-University of California Los Angeles Medical Center - Los Angeles
  • University of California Davis - Sacramento

Arizona

  • University of Airzona - Tucson

Colorado

  • University of Colordao - Aurora

District of Columbia

  • Children's National Hospital - Washington D.C.

Indiana

  • Indiana University - Indianapolis

North Carolina

  • Mecklenburg County Emergency Medical Services - Charlotte

Ohio

  • Nationwide Children's Hospital - Columbus

Texas

  • Dell Medical School, University of Texas at Austin - Austin

Trial Details

FieldValue
Enrollment Target 3,000 participants
Start Date 2024-05-20
Est. Completion 2029-09-30
Phase NA
Ohio State University

552 total trials

What NCT06364280 shows while recruiting

NCT06364280 is an interventional study that assigns participants to a tested intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 3,105-participant average among 91 other Critical Illness trials with a reported enrollment target.

The record links to 5 conditions, with Critical Illness appearing as the primary indexed condition, and to 3 interventions - of which BVM is the first listed.

NCT06364280 lists 10 locations in 9 states (California, Arizona, Colorado).

Frequently Asked Questions

What is clinical trial NCT06364280 about?

NCT06364280 is a clinical study titled "Pediatric Prehospital Airway Resuscitation Trial". This study is a Phase 3, multi-center, Bayesian Adaptive Sequential Platform Trial testing the effectiveness of different prehospital airway management strategies in the care of critically ill children. Emergency Medical Services (EMS) agencies affiliated with the Pediatric Emergency Care Applied Re...

What is the current status of trial NCT06364280?

This trial is currently recruiting. It is a NA study. The enrollment target is 3,000 participants. The study started on 2024-05-20. Estimated completion is 2029-09-30.

What conditions does trial NCT06364280 study?

This clinical trial studies the following conditions: Critical Illness, Wounds and Injuries, Child, Only, Heart Arrest, Out-Of-Hospital, Respiratory Insufficiency in Children.

What interventions are being tested in trial NCT06364280?

The interventions under investigation include: BVM (DEVICE), SGA (DEVICE), ETI (DEVICE).

Who is sponsoring clinical trial NCT06364280?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06364280 being conducted?

This trial has 10 study locations across Arizona, California, Colorado, District of Columbia, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Critical Illness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06364280's enrollment target sits among peer trials

3,000 7th of 91 higher than 84 of 91 other Critical Illness trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Critical Illness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00004847 · 3,000 participants · Phase 1

    Diagnosis of Pheochromocytoma

  • NCT00478712 · 3,000 participants

    Hirschsprung Disease Genetic Study

  • NCT00579566 · 3,000 participants

    Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma

  • NCT00816114 · 3,000 participants

    Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06364280

Source: ClinicalTrials.gov NCT06364280, the US trial registry maintained by the National Library of Medicine. NCT06364280 (large enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.